Thu, May 15, 9:36 PM (36 days ago)
**Helix Acquisition Corp. II (HLXB) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $0 (no operational revenue as the company is in the pre-combination stage). - **Net Loss:** $487,392 (Q1 2025) vs. Net Income: $1,100,442 (Q1 2024). - **Profit Margins:** Not applicable due to zero revenue. - **Cash Flow:** Net cash used in operating activities: $734,642 (Q1 2025) vs. $617,999 (Q1 2024). - **Cash Position:** $963,135 (Q1 2025) vs. $1,697,777 (Q4 2024). **Key Metrics & Trends:** - **Earnings Changes:** Significant decrease in net income, from a gain of $1,100,442 in Q1 2024 to a loss of $487,392 in Q1 2025. - **Expenses:** General and administrative expenses increased to $2,421,186 in Q1 2025 from $66,701 in Q1 2024. - **Interest Income:** Earned $1,989,268 on marketable securities held in the Trust Account in Q1 2025. - **Share-Based Compensation:** Increased to $57,919 in Q1 2025 from $39,372 in Q1 2024. **Uncertainties & Future Operations:** - **Going Concern:** The company lacks liquidity to sustain operations for a reasonable period, raising substantial doubt about its ability to continue as a going concern. - **Business Combination:** The company is in the process of completing a business combination with TheRas, Inc. (dba BridgeBio Oncology Therapeutics). - **Trust Account:** Holds $194,438,559 in marketable securities, which will be used to complete the business combination. - **Redemption:** Shareholders have the right to redeem their shares upon the completion of the business combination. **Impact on Future Operations:** - The successful completion of the business combination is crucial for the company's future operations and financial health. - The company's ability to identify and complete a business combination within the specified time frame will determine its long-term viability. - The company's financial condition and results of operations may be materially affected by various risks, including market conditions, regulatory changes, and the outcome of the business combination.